Literature DB >> 7957272

Successful treatment of Toxoplasma gondii myocarditis in an AIDS patient.

H Albrecht1, H J Stellbrink, S Fenske, H Schäfer, H Greten.   

Abstract

Central nervous system disease due to Toxoplasma gondii is a common cause of morbidity and mortality in patients with the acquired immunodeficiency syndrome. Cardiac toxoplasmosis, however, has been described in only a limited number of cases. In a 45-year-old patient with symptoms suggestive of myocarditis, Toxoplasma gondii was detected in myocardial tissue obtained by biopsy. After the institution of appropriate antiprotozoal therapy, the patient recovered. This patient is believed to be the first patient to survive biopsy-proven myocarditis caused by Toxoplasma gondii. Cardiac toxoplasmosis should be ruled out in HIV-infected patients presenting with high fever and/or cardiorespiratory symptoms and exhibiting serologic evidence of prior exposure to Toxoplasma gondii as determined by a positive IgG EIA, especially if the CD4+ count is low and no systemic Pneumocystis carinii pneumonia prophylaxis has been administered. A high index of clinical suspicion and, if necessary, invasive diagnostic tests, including myocardial biopsies, are most important in making the correct diagnosis.

Entities:  

Mesh:

Year:  1994        PMID: 7957272     DOI: 10.1007/BF01974642

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  12 in total

Review 1.  [Acute toxoplasmic myocarditis. A cause of sudden death in a case of acquired immunodeficiency syndrome].

Authors:  P Hoffman; E Bernard; J F Michiels; P Dellamonica; R Loubière
Journal:  Arch Mal Coeur Vaiss       Date:  1990-10

Review 2.  Toxoplasmic encephalitis.

Authors:  P R Mariuz; B J Luft
Journal:  AIDS Clin Rev       Date:  1992

3.  Isolated toxoplasma myocarditis in acquired immune deficiency syndrome.

Authors:  O V Adair; N Randive; N Krasnow
Journal:  Am Heart J       Date:  1989-10       Impact factor: 4.749

4.  Congenital cardiac toxoplasmosis in a newborn with acquired immunodeficiency syndrome.

Authors:  M D Medlock; J T Tilleli; G S Pearl
Journal:  Pediatr Infect Dis J       Date:  1990-02       Impact factor: 2.129

Review 5.  Toxoplasmosis in the adult.

Authors:  J S Remington
Journal:  Bull N Y Acad Med       Date:  1974-02

Review 6.  Congenital toxoplasmosis: clinical, laboratory, and therapeutic considerations, with special reference to subclinical disease.

Authors:  C A Alford; S Stagno; D W Reynolds
Journal:  Bull N Y Acad Med       Date:  1974-02

7.  Disseminated toxoplasmosis in the acquired immunodeficiency syndrome.

Authors:  D Tschirhart; E C Klatt
Journal:  Arch Pathol Lab Med       Date:  1988-12       Impact factor: 5.534

8.  Cardiac toxoplasmosis in pathology of acquired immunodeficiency syndrome.

Authors:  L Matturri; P Quattrone; C Varesi; L Rossi
Journal:  Panminerva Med       Date:  1990 Oct-Dec       Impact factor: 5.197

9.  Prevalent myocarditis at necropsy in the acquired immunodeficiency syndrome.

Authors:  D W Anderson; R Virmani; J M Reilly; T O'Leary; R E Cunnion; M Robinowitz; A M Macher; U Punja; S T Villaflor; J E Parrillo
Journal:  J Am Coll Cardiol       Date:  1988-04       Impact factor: 24.094

10.  Toxoplasma gondii serology in HIV-infected patients: the development of central nervous system toxoplasmosis in AIDS.

Authors:  I H Grant; J W Gold; M Rosenblum; D Niedzwiecki; D Armstrong
Journal:  AIDS       Date:  1990-06       Impact factor: 4.177

View more
  1 in total

Review 1.  Importance of nonenteric protozoan infections in immunocompromised people.

Authors:  J L N Barratt; J Harkness; D Marriott; J T Ellis; D Stark
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.